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Abstract
Background:  Many protocols for recombinant production of peptides and proteins include
secretion into the periplasmic space of Escherichia coli, as they may not properly fold in the
cytoplasm. If a signal peptide is not sufficient for translocation, a larger secretion moiety can instead
be fused to the gene of interest. However, due to the covalent linkage of the proteins, a protease
recognition site needs to be introduced in between, altering the N-terminus of the product. In the
current study, we combined the ubiquitin fusion technology, which allows production of authentic
peptides and proteins, with secretion by the perpiplasmic protease inhibitor ecotin.
Results: Different fusion constructs, composed of ecotin, mouse ubiquitin b and a model peptide,
were expressed in E. coli BL21(DE3). The fusion proteins were translocated into the periplasmic
space and the ecotin signal peptide was cleaved off. Under the control of the lacUV5 promoter at
24°C we obtained 18 mg periplasmic recombinant protein per gram dry cell weight. However,
vigorous expression with the T7 promoter caused outer membrane permeabilization and leakage
of the fusion protein into the culture medium. Target peptides were released from hybrid proteins
by the deubiquitinating enzyme ubiquitin c-terminal hydrolase-L3 in vitro. MALDI TOF-TOF mass
spectroscopy confirmed accurate cleavage.
Conclusion: This newly described method represents a useful technique for the production of
authentic soluble peptides in the periplasm of E. coli. In addition, larger proteins might also be
produced with the current system by the use of ubiquitin specific proteases, which can cleave off
larger C-terminal extensions.
Background
The gram-negative bacterium E. coli is widely used as host
for the production of recombinant proteins, due to well-
known genetics, simple handling and inexpensive fast
high-density cultivations [1,2]. Recombinant expressed
proteins in E. coli can be directed to the cytoplasm, inner
or outer membrane, periplasm or the growth medium.
Cytoplasmatic expression is desired because of high yields
of soluble product [3], but recombinant protein may
accumulate in inclusion bodies (IB). Although biologic
activity must be restored by in vitro renaturation proce-
dures [4], IB can be valuable for heterologous gene expres-
sion [5]. One strategy to prevent IB formation involves
fusion of the gene of interest downstream of the small
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eukaryotic protein ubiquitin [6]. The ubiquitin moiety
enhances fusion protein yield and increases solubility due
to intrinsic chaperonin properties [7]. This fusion system
also allows production of proteins and peptides with an
authentic N-terminus by the use of deubiquitinating
enzymes (DUB), cleaving the amide bond at the C-termi-
nus of ubiquitin [8]. As E. coli lacks the ubiquitin system,
release of target products can be conducted by protease
addition [9,10].
Protein export out of the cytoplasm has several advantages
compared to intracellular production, due to 1) better
folding (especially if disulfide-bond formation is
required), 2) simplified downstream processing, 3) higher
stability, 4) and correct N-terminal processing [11,12].
Translocation of target proteins across the inner mem-
brane requires a signal peptide. However, presence of a
signal sequence alone does not ensure secretion into the
periplasmic space [13,14]. Thus, a larger secretion moiety
can be linked to the target gene. Recently, a secretion sys-
tem was described, using the periplasmic protease inhibi-
tor ecotin [15] as fusion partner for the production of
native pepsinogen and proinsulin in E. coli [16,17].
In the present work we established a new expression sys-
tem, combining periplasmic secretion and the ubiquitin
fusion technology. We secreted different fusion proteins,
consisting of ecotin, mouse ubiquitin b and a target peptide.
A deubiquitinating enzyme precisely cleaved off peptides
from recombinant fusion proteins in vitro.
Methods
Water used in all experiments was Milli-Q ultrapure water
(Millipore purification system). Transformed E. coli cells
were cultivated in TY growth medium supplemented with
50 μg/ml kanamycin. For recombinant plasmid isolation
E. coli K12 DH5α strain was used, whereas protein expres-
sion was performed in BL21(DE3).
Restriction enzymes, GoTaq® DNA polymerase, including
the PCR buffer, were from Promega. Molecular mass
standard used for SDS-PAGE, rapid DNA ligation kit, Pfu
DNA polymerase and 10 × MgSO4-PCR buffer were
obtained from Fermentas. Tris-Glycine gels were pur-
chased from Invitrogen. Protran BA 83 nitrocellulose
membrane was obtained from Whatman, polyvinylidene
difluoride (PVDF) membrane from Hybond. mouse anti-
GroEL monoclonal antibody was purchased from Stress-
gen Bioreagents, goat anti-Mouse IgG (HRP conjugated)
from Invitrogen, anti-Maltose Binding Protein (MBP)
monoclonal antibody (HRP conjugated) from New Eng-
land Biolabs. Syringe filters (pore size 0.45 μm) were from
Sartorius, 10 kDa molecular weight cut-off ultrafiltration
devices (Centriprep Ultracel YM-10 tubes, series 8000
stirred cell including Ultracel YM-10 membranes) from
Millipore. Gravity flow Strep-Tactin® Sepharose® column
and Strep-Tactin® HRP conjugate were obtained from IBA.
The BCA™ protein assay kit was obtained from Pierce.
Rabbit ubiquitin C-terminal hydrolase-L3 (UCH-L3) was
from Sigma.
Construction of expression plasmids
A Strep-Tag II octapeptide (abbreviated Strep) was fused
C-terminal to each construct, allowing immunodetection.
The ecotin gene [GenBank: M60876] was amplified from
the E. coli K12 DH5α strain with GoTaq® DNA polymer-
ase, using the primers NdeI Ecotin F and Ecotin-Strep SalI
R (Table 1). The amplified fragment was ligated into NdeI
and SalI digested pET30a vector, resulting in pET30a Eco-
tin-Strep (Table 2).
A three-step gene assembly with Pfu DNA Polymerase gen-
erated the Ecotin-Ubiquitin-Strep fusion. First, ecotin with
an ubiquitin extension was amplified from vector pET30a
Ecotin-Strep with the primers NdeI Ecotin F and Ecotin-
Ubi (AS2–7) R. Next, ubiquitin [GenBank: NM_011664]
was obtained from another plasmid with the Ubi (AS2–7)
Table 1: Oligonucleotides used in this study
Primersa Sequences (5'-3')
NdeI Ecotin F GATATACATATGAAGACCATTCTACCTGCAGTA
Ecotin-Strep SalI R TATAGTCGACTTATTTTTCGAACTGCGGGTGGCTCCAGCGAACTACCGCGTTGTCAAT
Ecotin-Ubi (AS2–7) R CAGGGTCTTCACGAAGATCTGGCGAACTACCGCGTTGTCAAT
Ubi (AS2–7) F CAGATCTTCGTGAAGACCCTGACC
Ubi-Strep XhoI R TATACTCGAGTTATTTTTCGAACTGCGGGTGGCTCCAGCCACCCCTCAGACGGAGGAC
lacUV5p SphI F CCCAGGCTTTACACTTTATGCTTCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTT
lacUV5p XbaI R CTAGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGCATG
Ubi-FLS XhoI 1 F TATGAGTCGACCCTGCACCTGGTCCTCCGTCTCCGCGGTG
Ubi-FLS XhoI 2 R CCGCCACCTTTATCGTCATCATCTTTATAGTCACCACCGCGGAGACGGAG
Ubi-FLS XhoI 3 F ATGACGATAAAGGTGGCGGAGGTAGCGGTGGAGGAGGCAGCTGGAGCCAT
Ubi-FLS XhoI 4 R TATACTCGAGTTATTTTTCAAACTGCGGATGGCTCCAGCTGCCTC
a The oligonucleotides contain the letters: F – forward or R – reverseMicrobial Cell Factories 2009, 8:7 http://www.microbialcellfactories.com/content/8/1/7
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F and Ubi-Strep XhoI R oligonucleotides. Both genes were
linked and amplified in a follow up PCR with the primers
NdeI Ecotin F and Ubi-Strep XhoI R. The resulting frag-
ment was cloned into NdeI and XhoI digested pET30a vec-
tor.
The pET30a T7 promoter (T7p) was exchanged in differ-
ent vectors with the artificial lacUV5 promoter (lacUV5p).
Two oligonucleotides with 65 complementary bases,
lacUV5p SphI F and lacUV5p XbaI R, were directly ligated
into SphI and XbaI digested pET30a plasmids.
The SalI cleavage site within the ubiquitin gene was used to
couple the new target peptide FLS to its C-terminus. The
peptide coding sequence, including a c-terminal part of
ubiquitin, was generated with a two-step gene synthesis
protocol using Pfu  DNA polymerase. Complementary
Ubi-FLS XhoI primers were annealed and extended during
a first PCR procedure. A second PCR run with the primers
Ubi-FLS XhoI 1 F and Ubi-FLS XhoI 4 R generated the full-
length product. Insertion into SalI and XhoI cleaved
pET30a lacUV5p Ecotin-Ubiquitin-Strep led to formation of
the new fusion gene Ecotin-Ubiquitin-FLS (Fig. 1).
Small scale fermentation
Expression plasmids were transformed in E. coli
BL21(DE3) and overnight cultures inoculated at 37°C
and 225 rpm. The cultures were diluted 1:15 with fresh
medium and grown to an OD600 of 0.5–0.7 at 37°C.
Recombinant protein synthesis was induced adding 1 mM
IPTG. Expression with T7p was carried out for 3 h at 37°.
In contrast cells carrying pET30 lacUV5p plasmids were
incubated at 24°C for 3 to 5 h.
Cell fractionation
Isolation of the periplasm was performed at 24°C with a
gentle osmotic shock procedure to minimize E. coli cell
disruption during preparation (modified from [18]). After
expression, a given culture volume (OD600 between 1.5
and 3.0) was centrifuged at 3000 g for 10 min and the
supernatant filtrated through a 0.45 μm membrane. The
pellet was completely suspended in one culture volume of
osmolysis buffer (100 mM TRIS-HCl pH 7.8, 15.4%
sucrose, 3 mM EDTA) and incubated at 50 rpm for 10
min, followed by centrifugation. The supernatant was dis-
carded and the pellet dissolved in one culture volume
water for 10 min at 50 rpm. Afterwards the suspension
was centrifuged for 15 min at 3000 g. The supernatant,
containing periplasmic proteins, was decanted and fil-
Table 2: Plasmids and corresponding expression products
Vectorsa Gene cloned Resulting vectorsa Expression product
pET30a Ecotin-Strep pET30a Ecotin-Strep Ecotin-Strep
pET30a Ecotin-Ubiquitin-Strep pET30a Eco-Ubi-Strep Ecotin-Ubiquitin-Strep
pET30a lacUV5p Ecotin-Ubiquitin-Strep pET30a lacUV5p Ecotin-Ubiquitin-Strep Ecotin-Ubiquitin-Strep
pET30a lacUV5p Ecotin-Ubiquitin-Strep FLS pET30a lacUV5p Ecotin-Ubiquitin-FLS Ecotin-Ubiquitin-FLS
a plasmids with the lacUV5 promoter are named pET30a lacUV5p
Schematic representation of the vector used for Ecotin-Ubiquitin-FLS expression Figure 1
Schematic representation of the vector used for Ecotin-Ubiquitin-FLS expression. Amino acids of the correspond-
ing genes are numbered. Full-length ecotin with the intrinsic signal sequence (1–20) was cloned upstream of mouse ubiquitin B 
(ubi, 2–76), followed by the FLS (1–26) target peptide. The cleavage site for a deubiquitinating enzyme (DUB) is indicated with 
an arrow. A SacII cleavage was introduced at the ubiquitin C-terminus by PCR. t0, transcription termination region.Microbial Cell Factories 2009, 8:7 http://www.microbialcellfactories.com/content/8/1/7
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trated (membrane, 0.45 μm pore size). Subsequently, the
spheroblasts were taken up in a culture volume lysis
buffer (20 mM Na2HPO4 pH 8.0, 75 mM NaCl, 5 mM
EDTA) and disrupted with a French press (American
Instruments Co., Inc). Aliquots of the lysate were collected
and centrifuged at 14000 rpm for 15 min. The superna-
tant contained soluble cytoplasmic protein, whereas the
pellet represented the insoluble protein fraction. For SDS-
PAGE analysis culture supernant, periplasmic and cyto-
plasmic fraction samples were precipitated with TCA and
all pellets solubilized in loading buffer (62.5 mM Tris-
HCl pH 6.8, 10% glycerol, 2% SDS, 0.0025% bromophe-
nol blue, 50 mM DTT).
Concentration and purification of recombinant protein
For the scaled process, 25 ml 10 × buffer W (1 M Tris-HCl
pH 8.0, 1.5 M NaCl, 10 mM EDTA) were mixed with 225
ml filtrated periplasm. Then the suspension was concen-
trated to 1 ml with ultrafiltration devices. After removal of
precipitated proteins by centrifugation, the supernatant
was applied on a preequilibrated 1 ml gravity flow Strep-
Tactin®  Sepharose®  column and purified. Recombinant
protein was eluted in 6 × 0.5 ml buffer EB (100 mM Tris-
HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 2 mM desthio-
biotin). The eluate fractions were pooled and concen-
trated to 1 ml with a Centriprep YM-10 tube.
Enzymatic digestion reaction
Enzymatic digestions of fusion proteins were performed
in vitro at 20°C with 0.05 nmol/ml rabbit UCH-L3 and an
enzyme/substrate molar ratio of up to1:2750. Either raw
periplasmic extract or Strep-Tactin purified recombinant
protein (in buffer EB) were used for cleavage. If extract
served as substrate it first had to be adapted to UCH reac-
tion buffer conditions (50 mM Tris-HCl pH 8.5, 1 mM
EDTA). To achieve maximal enzyme activity, 10 mM MTG
or DTT were added to the digestion solution. Cleavage
was stopped by addition of TCA or storage at 4°C.
Western blots
Cellular integrity after expression and osmotic shock treat-
ment was surveyed by Western blots with antibodies to
the periplasmic MBP, and cytoplasmic GroEL marker pro-
teins. Full-length recombinant protein, including Strep-
Tag II, was detected with Strep-Tactin® HRP conjugate.
Cell fraction samples were separated on 4–20% Tris-Gly-
cine gels and the proteins electrophoretically transferred
onto nitrocellulose membranes.
Protein quantification
Quantitative densitometric analysis of target proteins in
comparison to BSA standards on Coomassie stained gels
assessed secretion efficiency. Gels were photographed and
analyzed with AlphaEaseFC software (Alpha Innotech
Corporation). Protein concentration of purified recom-
binant protein was determined with the BCA™ protein
assay.
N-terminal amino acid sequencing
Recombinant protein (~100 pmol) was blotted onto a
PVDF membrane, the Coomassie stained band excised
with a razor blade and sequencing performed by auto-
mated Edman degradation with a Procise Model 492
micro-sequencer (Applied Biosystems, Norwalk, CT).
Mass spectrometry
Single and tandem mass spectroscopy was done for puri-
fied Ecotin-Ubiquitin-FLS after UCH-L3 digestion (4800
Plus MALDI TOF/TOF™ Analyzer, Applied Biosystems,
Norwalk, CT).
Results and discussion
Control expression of ecotin
First, we surveyed if Strep-Tag II labeled ecotin could be
secreted into the periplasm by conventional expression
with the pET system at 37°C. SDS-PAGE analysis of the
cellular fractions unveiled two different products (see
additional file 1: Ecotin-Strep expression with the pET sys-
tem). The larger protein resembled unprocessed Ecotin-
Strep, where the signal sequence had not been cleaved off
by E. coli signal peptidase. It was mainly sequestered in IB.
The smaller product instead was predominantly directed
to the culture supernatant and the signal peptide cleaved
off (the sequence AESV after the cleavage site was con-
firmed by N-terminal amino acid sequencing). As Maltose
Binding Protein was detected in the culture supernatant
we suggested that outer membrane leakage was responsi-
ble for extracellular secretion [19,20].
Expression of the Ecotin-Ubiquitin-Strep fusion protein
Since ecotin was efficiently expressed and secreted it was
used to promote translocation of ubiquitin.  Ecotin  and
Ubiquitin-Strep  were fused by PCR, introduced into
pET30a and expressed at 37°C. Cell fractionation was sur-
veyed by Western blots using anti-GroEL and-MBP anti-
bodies. Ecotin-Ubiquitin-Strep protein behaved similar to
Ecotin-Strep. Processed fusion protein was detected
mainly in the culture medium, the uncleaved variant
instead aggregated in IB (Fig. 2A).
Inclusion bodies can form when the capacity of the export
machinery is overwhelmed by the amount of recom-
binant protein. Reducing the expression rate can therefore
reduce IB formation [21-23]. Thus, we exchanged the T7
promoter (T7p) with the weaker artificial lacUV5 pro-
moter (lacUV5p) and conducted all further expressions at
24°C. Under these conditions nearly the entire recom-
binant protein was translocated into the periplasm (Fig.
2B) and the signal peptide cleaved off. Outer membrane
permeabilization and IB formation were not observed. AMicrobial Cell Factories 2009, 8:7 http://www.microbialcellfactories.com/content/8/1/7
Page 5 of 9
(page number not for citation purposes)
concentration of ~18 mg periplasmic fusion protein g-1
dry cell weight was obtained as calculated by quantitative
densitometry.
Cleavage reactions with UCH-L3
Whereas ubiquitin fusion proteins are endogenously
processed in yeast, cleavage of recombinant protein in E.
coli requires either in vivo co-expression of a DUB [10] or
in vitro proteolytic digestion [9]. Since cytoplasmic cleav-
age of the Ecotin-Ubiquitin-Tag would interfere with
secretion of target product, hydrolysis had to be carried
out in vitro.
In our experiments we used Ubiquitin C-terminal hydro-
lase-L3, which cleaves small peptide extensions with high
efficiency and low sequence preference, except those con-
taining proline at the scissile bond [24]. We assessed if the
Strep-Tag II peptide with 8 amino acids (aa) in length
could be released from periplasmic Ecotin-Ubiquitin-
Strep fusion protein by in vitro digestion. Crude periplas-
mic extract of an expression was taken up in UCH reaction
buffer including DTT. The solution was subsequently
incubated with 0.05 nmol UCH-L3 enzyme per ml reac-
tion volume, corresponding to a 1:9 enzyme/substrate
molar ratio. TCA precipitated periplasmic extract served as
negative control. Cleavage was efficient and almost com-
plete after 2 h of incubation (Fig. 3A). Strep-Tag II release
from the fusion protein resulted in a band shift on the gel
and weakening of the Strep-Tactin® HRP immunoblot sig-
nal compared to the untreated control.
Next, we exchanged the Strep-Tag II with a larger cleavage
target. The model peptide FLS (26 aa) consisted of the
FLAG and Strep-Tag II octapeptides that were linked by a
flexible region. After expression of Ecotin-Ubiquitin-FLS
and osmolysis, the periplasmic fraction was treated as
described above and digested for 16 h. The periplasm was
also incubated in cleavage reaction buffer without UCH-
L3 enzyme to exclude digestion by endogenous E. coli pro-
teases. Cleavage was observed in the digestion sample, but
not in the controls (Fig. 3B). Thus, release of FLS was
exclusively caused by UCH-L3.
Purification, preparative cleavage and verification of the 
FLS peptide
Several working groups obtained different peptides and
proteins from cytoplasmatic expressed ubiquitin  fusion
Cellular localization of Ecotin-Ubiquitin-Strep depending on different expression conditions Figure 2
Cellular localization of Ecotin-Ubiquitin-Strep depending on different expression conditions. Expression and 
secretion of fusion proteins was analyzed by SDS-PAGE. Western blots with antibodies to the periplasmic MBP and cytoplas-
mic GroEL marker proteins assessed proper cell fractionations. A) Cultivation at 37°C with T7 promoter, B) lacUV5p-depend-
ant expression at 24°C. M: protein marker, -I and +I: before and after induction of expression, IB: inclusion bodies, Cyt: 
cytoplasm, Per: periplasm, CS: culture supernatant. The arrow indicates secreted fusion protein (25.55 kDa).Microbial Cell Factories 2009, 8:7 http://www.microbialcellfactories.com/content/8/1/7
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proteins [25-29]. An N-terminal affinity tag (e.g. 6His)
was often fused to ubiquitin, simplifying purification.
In the current study we cloned the full-length ecotin gene
upstream of ubiquitin. Although our results indicated
cleavage at the C-terminus of ubiquitin by UCH-L3 it was
necessary to confirm specific hydrolysis of the α-amide
bond following glycine 76. Thus, we determined the
molecular mass of released FLS. First, nine volumes fil-
trated periplasm, containing Ecotin-Ubiquitin-FLS, were
mixed with one volume 10× buffer W. The solution was
then concentrated by a factor of 250 and the fusion pro-
tein purified by Strep-Tactin® Sepharose® affinity chroma-
tography. The eluate fractions were pooled, concentrated
to 1 ml and hydrolysis carried out for 13 h with UCH-L3
(Fig. 4). The digestion probe had a purity of >95% (SDS-
PAGE) with a total protein concentration of 2.24 mg/ml
(recovery rate of recombinant protein, 78%). Accordingly
the enzyme/substrate molar ratio was ~1:1650. Since ≥
96% (as determined by densitometry of SDS-PAGE) of the
fusion protein molecules have been cleaved by UCH-L3
the sample was directly analyzed by MALDI TOF/TOF
mass spectroscopy (MS). The predicted mass of the FLS
peptide was accurately determined (Fig. 5) and the pep-
tide identity also confirmed in a collision-induced disso-
ciation (CID) fragmentation analysis (see additional file
2: De novo sequencing of the putative FLS peptide by CID
MS/MS).
We suggest that also larger peptides and proteins can be
produced with the new technique by the use of deubiqui-
tinating enzymes that cleave fusion proteins irrespective
of their size. For instance, hydrolysis could be conducted
with S. cerevisae ubiquitin-specific protease I [30] or the
D2QL analogue [31]. The yield of target products may
also be increased replacing ecotin with a smaller secretion
moiety. However, one should consider that in fact certain
ubiquitin fusion proteins are accurately cleaved in vivo in
E. coli [28]. Although bacteria do not have an intrinsic
ubiquitin system, various deubiquitinating proteases were
found in several strains [32-34]. These endogenous ubiq-
uitin-processing enzymes might interfere with the ubiqui-
tin fusion system, reducing desired product yield. For
general application of the system genomic deletion of
these enzymes should be considered. The first amino acid
of the target product should also be taken into account as
alterations influence the expression rate of the fusion pro-
tein in yeast [25].
Conclusion
We developed a novel system for the production of small
peptides in E. coli. Different fusion proteins were gener-
Release of the (A) Strep and (B) FLS peptides from Ecotin-Ubiquitin fusion proteins by UCH-L3 Figure 3
Release of the (A) Strep and (B) FLS peptides from Ecotin-Ubiquitin fusion proteins by UCH-L3. Expression and 
cleavage of the fusion proteins in the periplasmic extract was analyzed by SDS-PAGE and Strep-Tactin® HRP immunoblots. M: 
protein marker, -I and +I: before and after induction of expression, IB: inclusion bodies, Cyt: cytoplasm, Per: 1 × and 5×, single 
and fivefold amount of periplasmic protein, c1: periplasmic extract untreated, c2: periplamic extract incubated in UCH buffer, 
*: UCH-L3 digested periplasm, CS: culture supernatant. The upper arrow indicates intact fusion protein, the lower one with 
the asterisk the major cleavage moiety Ecotin-Ubiquitin (24.51 kDa).Microbial Cell Factories 2009, 8:7 http://www.microbialcellfactories.com/content/8/1/7
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Purification of Ecotin-Ubiquitin-FLS from periplasmic concentrate by Strep-Tactin® affinity chromatography and follow-up  cleavage with UCH-L3 Figure 4
Purification of Ecotin-Ubiquitin-FLS from periplasmic concentrate by Strep-Tactin® affinity chromatography 
and follow-up cleavage with UCH-L3. PerC: concentrated periplasmic solution, pellet (P) and supernatant (S). Fractions of 
the corresponding purification steps are numbered. Fl: flow-through, Wa: wash, El: elution, *: digestion of concentrated eluate 
(El 1–6) with UCH-L3 for 13 h. The upper lane represents intact recombinant protein. The cleavage product Ecotin-Ubiquitin 
is labeled with an asterisk.
Maldi TOF/TOF mass spectroscopic spectre for UCH-L3 digested Ecotin-Ubiquitin-FLS in the m/z range 799–4013 Figure 5
Maldi TOF/TOF mass spectroscopic spectre for UCH-L3 digested Ecotin-Ubiquitin-FLS in the m/z range 799–
4013. The peaks at 2683 and 1342 represent the single and double protonation states of the FLS peptide, respectively.
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ated, consisting of the periplasmic protease inhibitor eco-
tin, mouse ubiquitin b and either the target peptide Strep-
Tag II (8 aa) or FLS (26 aa). Ecotin, encoding a 142 amino
acid monomer with an implied signal peptide [35], was
used to promote secretion. Ubiquitin served as substrate
for rabbit ubiquitin c-terminal hydrolase-L3 to cleave off
the target peptides. A further function was to enhance the
fusion protein solubility. With our shake flask fermenta-
tions at 24°C we produced 18 mg periplasmic recom-
binant fusion protein per gram dry cell weight,
corresponding to 0.75 mg Strep-Tag, respectively 1.78 mg
FLS. Both peptides were efficiently removed from ubiqui-
tin by UCH-L3 at an enzyme/substrate molar ratio of up
to 1:2750. Thus, ecotin did not impede cleavage. Accurate
digestion was confirmed by MALDI TOF/TOF mass spec-
troscopy for the FLS peptide, followed by de novo MS/MS
sequencing.
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